Patents Assigned to Immunetics
  • Patent number: 10254293
    Abstract: The invention is directed to methods of using novel Babesia antigen peptides in detecting Babesia spp. in a sample. The methods may be adapted to assays suitable for high blood volume screening, use for clinical diagnosis of patients with babesiosis, or assaying blood contaminated with Babesia spp., such as B. microti.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: April 9, 2019
    Assignee: IMMUNETICS, INC.
    Inventors: James L. Erwin, III, Neil X. Krueger, Andrew E. Levin
  • Patent number: 9879301
    Abstract: The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)-?-D-glucan in a sample.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: January 30, 2018
    Assignee: IMMUNETICS, INC.
    Inventors: Neil X. Krueger, Andrew Han, Andrew E. Levin, Victor Kovalenko
  • Publication number: 20140329304
    Abstract: The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)-?-D-glucan in a sample.
    Type: Application
    Filed: December 4, 2013
    Publication date: November 6, 2014
    Applicant: Immunetics, Inc.
    Inventors: Andrew Bodkin, Mark Villafuerte, Hendrick Melo, Neil X. Krueger, Andrew Han, Andrew E. Levin
  • Patent number: 8841086
    Abstract: The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)-?-D-glucan in a sample.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: September 23, 2014
    Assignee: Immunetics, Inc.
    Inventors: Andrew Han, Andrew E. Levin, Neil X. Krueger, Victor Kovalenko
  • Publication number: 20140011218
    Abstract: The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)-?-D-glucan in a sample.
    Type: Application
    Filed: May 21, 2013
    Publication date: January 9, 2014
    Applicant: Immunetics, Inc.
    Inventors: Andrew Han, Andrew E. Levin, Neil X. Krueger, Victor Kovalenko
  • Publication number: 20130244258
    Abstract: The invention is directed to methods of using novel Babesia antigen peptides in detecting Babesia spp. in a sample. The methods may be adapted to assays suitable for high blood volume screening, use for clinical diagnosis of patients with babesiosis, or assaying blood contaminated with Babesia spp., such as B. microti.
    Type: Application
    Filed: October 22, 2012
    Publication date: September 19, 2013
    Applicant: IMMUNETICS, INC.
    Inventors: James L. Erwin, III, Neil X. Krueger, Andrew E. Levin
  • Patent number: 8450079
    Abstract: The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)-?-D-glucan in a sample.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: May 28, 2013
    Assignee: Immunetics, Inc.
    Inventors: Victor Kovalenko, Andrew E. Levin
  • Publication number: 20110245094
    Abstract: The present invention features, inter alia, compositions and methods useful for identifying one or more types of microorganisms, if and when present, in a sample or plurality of samples (e.g., in one or more samples tested in parallel). More specifically, the present compositions and methods can be used in, e.g., determining whether a subject has a microbial infection (e.g., a bacterial, fungal, protozoal, or viral infection), determining the identity of the microbe(s) causing the infection, and/or determining, or helping to determine, an appropriate anti-microbial treatment regimen for a subject identified as having an infection (e.g., an appropriate antibiotic, anti-fungal, anti-viral, or other treatment regimen).
    Type: Application
    Filed: May 1, 2009
    Publication date: October 6, 2011
    Applicant: IMMUNETICS, INC.
    Inventors: Brian K. Washburn, Andrew E. Levin
  • Publication number: 20100227353
    Abstract: The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)-?-D-glucan in a sample.
    Type: Application
    Filed: October 6, 2009
    Publication date: September 9, 2010
    Applicant: Immunetics, Inc.
    Inventors: Victor Kovalenko, Andrew E. Levin
  • Patent number: 7598054
    Abstract: The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)-?-D-glucan in a sample.
    Type: Grant
    Filed: April 28, 2006
    Date of Patent: October 6, 2009
    Assignee: Immunetics, Inc.
    Inventors: Victor Kovalenko, Andrew E. Levin, Lee Anne Beausang
  • Patent number: 7262019
    Abstract: The invention provides a heterogeneous immunoassay for detection of antibodies and antigens based on specific antigen-antibody immune complex formation with multiple antigen-bearing conjugate components. The invention further provides means for optimizing the assay format for the detection of both low and high-affinity antibodies, and provides means for quantitative detection of both antibody and the corresponding antigen present in a sample. In preferred embodiments, the invention can be practiced to detect presence in biological fluid samples of antibodies to Bacillus anthracis related antigens.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: August 28, 2007
    Assignee: Immunetics, Inc.
    Inventor: Victor Kovalenko
  • Publication number: 20070178542
    Abstract: The invention provides a heterogeneous immunoassay for detection of antibodies and antigens based on specific antigen-antibody immune complex formation with multiple antigen-bearing conjugate components. The invention further provides means for optimizing the assay format for the detection of both low and high-affinity antibodies, and provides means for quantitative detection of both antibody and the corresponding antigen present in a sample. In preferred embodiments, the invention can be practiced to detect presence in biological fluid samples of antibodies to Bacillus anthracis related antigens.
    Type: Application
    Filed: May 24, 2004
    Publication date: August 2, 2007
    Applicant: Immunetics, Inc.
    Inventor: Victor Kovalenko
  • Publication number: 20070148707
    Abstract: The invention provides a heterogeneous immunoassay for detection of antibodies and antigens based on specific antigen-antibody immune complex formation with multiple antigen-bearing conjugate components. The invention further provides means for optimizing the assay format for the detection of both low and high-affinity antibodies, and provides means for quantitative detection of both antibody and the corresponding antigen present in a sample.
    Type: Application
    Filed: August 25, 2006
    Publication date: June 28, 2007
    Applicant: Immunetics, Inc.
    Inventor: Victor Kovalenko
  • Publication number: 20060269982
    Abstract: The invention relates to a colorimetric method for detecting bacterial or fungal pathogens by detecting peptidoglycan or (1-3)-?-D-glucan in a sample.
    Type: Application
    Filed: April 28, 2006
    Publication date: November 30, 2006
    Applicant: Immunetics, Inc.
    Inventors: Victor Kovalenko, Andrew Levin, Lee Anne Beausang
  • Patent number: 7125517
    Abstract: The invention provides a heterogeneous immunoassay for detection of antibodies and antigens based on specific antigen-antibody immune complex formation with multiple antigen-bearing conjugate components. The invention further provides means for optimizing the assay format for the detection of both low and high-affinity antibodies, and provides means for quantitative detection of both antibody and the corresponding antigen present in a sample.
    Type: Grant
    Filed: August 9, 2004
    Date of Patent: October 24, 2006
    Assignee: Immunetics, Inc.
    Inventor: Victor A. Kovalenko
  • Patent number: 7105311
    Abstract: The invention provides a heterogeneous immunoassay for detection of antibodies and antigens based on specific antigen-antibody immune complex formation with multiple antigen-bearing conjugate components. The invention further provides means for optimizing the assay format for the detection of both low and high-affinity antibodies, and provides means for quantitative detection of both antibody and the corresponding antigen present in a sample.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: September 12, 2006
    Assignee: Immunetics, Inc.
    Inventor: Victor Kovalenko
  • Patent number: 6303389
    Abstract: The invention includes assay cassettes that can be employed during rapid flow-through binding assays. The assay cassettes can be disposable units suitable for one-time use and readily assembled to include a filter membrane carried between an upper plate and a lower plate. A pattern of channels can extend through the top plate to allow a fluid sample to be applied through the top plate and onto the filter. The bottom plate can include a plurality of channels that are aligned with the channel of the top plate and which will allow a negative pressure to be applied to the underside of the filter membrane to draw the sample through the filter. In one embodiment, the cassette includes a frangible section that allows the cassette to be divided into a first and second component.
    Type: Grant
    Filed: June 29, 1998
    Date of Patent: October 16, 2001
    Assignee: Immunetics
    Inventors: Andrew E. Levin, William Bowers
  • Patent number: 6194160
    Abstract: Systems and methods for processing membrane flow-through assays to provide more rapid testing. The systems include a plate for receiving a cartridge having a membrane which, for example, can be a membrane with antigens or antibodies fixed thereon. The agents can be pipetted onto the membrane and the systems can be activated to agitate the cartridge to evenly distribute the agents over the membrane, and a vacuum source can apply negative pressure to one side of the membrane to draw the agent therethrough.
    Type: Grant
    Filed: March 19, 1998
    Date of Patent: February 27, 2001
    Assignee: Immunetics, Inc.
    Inventor: Andrew E. Levin
  • Patent number: 6013460
    Abstract: Modified Western blot membranes and methods of using same are provided which allow confirmation of Lyme disease and screening for at least one additional tick-borne disease. The membranes and methods of the present invention may thus be used to screen for the presence of tick-borne diseases which may be transferred along with Lyme disease. A Western blot assay may also be employed to confirm the presence of such additional tick-borne disease.
    Type: Grant
    Filed: September 12, 1997
    Date of Patent: January 11, 2000
    Assignee: Immunetics, Incorporated
    Inventor: Andrew E. Levin
  • Patent number: D787682
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: May 23, 2017
    Assignee: IMMUNETICS, INC.
    Inventors: Michael J. Ockham, Richard A. Pinkowitz, Terese S. Farrell, Edward M. Keohan, James L. Dowling, Gregg Wilder